Curis
CRIS
#11142
Rank
โ‚น0.23 B
Marketcap
โ‚น95.86
Share price
-8.26%
Change (1 day)
-35.99%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2026 (TTM): -โ‚น2,165

According to Curis's latest financial reports the company's current EPS (TTM) is -โ‚น2,282. In 2025 the company made an earnings per share (EPS) of -โ‚น2,282 an increase over its 2024 EPS that were of -โ‚น13,478.

EPS history for Curis from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น2,165-5.1%
2025-โ‚น2,282-83.07%
2024-โ‚น13,478-22.15%
2023-โ‚น17,313-26.17%
2022-โ‚น23,44822.3%
2021-โ‚น19,173-25.37%
2020-โ‚น25,691-30.93%
2019-โ‚น37,195-2.02%
2018-โ‚น37,962
2016-โ‚น86,277-10%
2015-โ‚น95,863138.1%
2014-โ‚น40,26240%
2013-โ‚น28,759-25%
2012-โ‚น38,34566.67%
2011-โ‚น23,007

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น125.58-105.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น341.27-114.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-โ‚น34.51-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
โ‚น300.05-113.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น408.38-82.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-โ‚น483.15-78.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-โ‚น16.30-99.29%๐Ÿ‡บ๐Ÿ‡ธ USA